Statera Biopharma, Inc. reports

Company location: Fort Collins, CO
Fiscal year end: 31 December

Statera Biopharma, Inc. has filed 764 SEC EDGAR filings since 18 Feb 2005

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-22 of 22 matching filings.

Per page

Current page

SC 13G/A File 005-82030

SC 13G/A filing

Filing date: 15 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SC 13G/A filing

Filing date: 11 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 11 Jun 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SCHEDULE 13G - TXT FORMAT

Filing date: 24 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date: 28 Feb 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SABBY 13G-A CBLI 1.04.18

Filing date: 04 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

AMENDMENT NO.1 TO SCHEDULE 13G

Filing date: 03 Feb 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SABBY 13G-A CBLI 1.06.16

Filing date: 06 Jan 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SCHEDULE 13G

Filing date: 26 May 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SCHEDULE 13G

Filing date: 05 Feb 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SABBY 13G-A CBLI 01.09.15

Filing date: 09 Jan 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SABBY 13G CBLI 01.14.14

Filing date: 14 Jan 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SCHEDULE 13G/A

Filing date: 21 Mar 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SCHEDULE 13G/A

Filing date: 21 Mar 2012
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SC 13G/A filing

Filing date: 14 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-82030

SC 13G/A filing

Filing date: 14 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 04 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 04 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 11 Feb 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 11 Feb 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

SC 13G filing

Filing date: 11 Feb 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-82030

CLEVELAND BIOLABS, INC.

Filing date: 07 Jan 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing